<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02628678</url>
  </required_header>
  <id_info>
    <org_study_id>G006-HU-PD</org_study_id>
    <nct_id>NCT02628678</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers</brief_title>
  <official_title>An Open-label Study to Evaluate the Effect of Diet on the Tolerability of FOS, a Commercially Available Prebiotic, in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaleido Biosciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaleido Biosciences</source>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine the 5-day tolerability of one
      commercially available prebiotic food ingredient, FOS, in healthy human subjects with and
      without diet control.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of subjects with Adverse Events</measure>
    <time_frame>22 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The effect of controlling diet on the tolerability of FOS by analyzing the gut microbiome</measure>
    <time_frame>22 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>The effect of FOS on each subject's gut microbiome</measure>
    <time_frame>22 days</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Fructooligosaccharide (FOS)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects will be required to take 8 grams of FOS per day for a total of 10 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>FOS</intervention_name>
    <arm_group_label>Fructooligosaccharide (FOS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Be able to give written informed consent;

          2. Be male or female of any race, between 18 and 65 years of age;

          3. Have a BMI &gt; 20 &amp; &lt; 27 kg/m2;

          4. Be willing to follow a controlled low fiber diet for a period of 11 days;

        Exclusion Criteria:

          1. Are less than 18 and greater than 65 years of age;

          2. Are hypersensitive to any of the components of FOS;

          3. Are currently taking probiotic or prebiotic supplements, or have taken them in the
             past 28 days;

          4. Unwilling to avoid probiotics/prebiotics supplements for the duration of the study;

          5. Have a significant acute or chronic, unstable and untreated disease or any condition
             which contraindicates, in the investigators judgment, entry to the study;

          6. Subject is a smoker;

          7. Subject has a history of drug and/or alcohol abuse at the time of enrollment;

          8. Taken a medication that the investigator believes would interfere with the objectives
             of the study, pose a safety risk or confound the interpretation of the study results;

          9. Individuals who, in the opinion of the investigator, are considered to be poor
             attendees or unlikely for any reason to be able to comply with the trial;

         10. Subjects may not be receiving treatment involving experimental drugs;

         11. If the subject has been in a recent experimental trial, these must have been completed
             not less than 60 days prior to this study;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kaleido Biosciences</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2015</study_first_submitted>
  <study_first_submitted_qc>December 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2015</study_first_posted>
  <last_update_submitted>August 29, 2016</last_update_submitted>
  <last_update_submitted_qc>August 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prebiotic</keyword>
  <keyword>FOS</keyword>
  <keyword>fructooligosaccharide</keyword>
  <keyword>polyglycan</keyword>
  <keyword>microbiome</keyword>
  <keyword>microbiota</keyword>
  <keyword>Healthy Volunteers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

